2022 Diabetes-SIBO Meta-Analysis
14 studies, 1,417 diabetic patients, 649 controls
- • SIBO prevalence: 29% in diabetics (95% CI: 20-39%)
- • Odds ratio vs controls: 2.91, but imprecise (95% CI 0.82-10.32; not statistically significant)
- • Type 1 vs Type 2: Similar prevalence (25% vs 30%)
- • Western vs Eastern: 35% vs 24% prevalence
PMID: 35086065
SIBO and Beta-Cell Function (2020)
In a cross-sectional study of 104 people with type 2 diabetes, those with SIBO had:
- • Lower insulin release after a glucose challenge
- • Higher 2-hour glucose and HbA1c
- • A one-time snapshot: it can't show which came first
PMID: 32691685
Gastroparesis-SIBO Meta-Analysis (2023)
In patients with gastroparesis (common in diabetes):
- • SIBO prevalence: 41% (95% CI: 23-58%)
- • Six small studies with very different tests; results varied widely
PMID: 37070116
